The life sciences sector operates in highly regulated, multilingual environments, where clear and accurate translation can impact patient outcomes and product success. Specialized providers translate everything from lab reports and regulatory filings to genomic data and medical journals.
Common questions about life sciences translation answered by our team.
Life sciences translation covers professional language services for the biotechnology, pharmaceutical, medical device, clinical research, and agricultural science sectors. It requires translators with advanced scientific qualifications who can handle highly technical content in regulatory submissions, research publications, and product documentation. Translation Ratings lists 11 life sciences translation agencies in the United States.
Life sciences translation projects commonly include: clinical study protocols and reports (CSRs), regulatory submissions to the FDA, EMA, and other health authorities, investigational new drug (IND) applications, new drug applications (NDA) and biologics license applications (BLA), informed consent forms (ICFs), medical device technical files, pharmacovigilance and adverse event reports, scientific publications, product labeling and package inserts, and biotech patent applications.
Life sciences translation must comply with FDA regulations (21 CFR Parts 11, 50, 56, 312, 314 among others), ICH (International Council for Harmonisation) guidelines for pharmaceutical documentation, EU Clinical Trial Regulation (536/2014), ISO 13485 for medical devices, and EMA requirements for centralized marketing authorization applications. Regulatory submissions with translation errors can result in rejection, approval delays, and significant financial losses.
Consistency in terminology across all documents in a regulatory submission is critical. Regulatory reviewers will flag discrepancies in how drug names, dosage units, endpoint definitions, or adverse event terms are translated across different documents. Life sciences translation agencies use terminology databases (termbases) and translation memory to ensure that approved terms are used consistently throughout large multi-document submissions.
Life sciences translators should ideally hold advanced degrees (PhD or MSc) in biology, chemistry, pharmacology, medicine, biochemistry, or a closely related discipline. Experience working in a pharmaceutical company, CRO (contract research organization), or regulatory affairs is highly valuable. Familiarity with ICH guidelines, GCP (Good Clinical Practice), and regulatory submission formats (eCTD) distinguishes top-tier life sciences translators.
Leading life sciences translation agencies operate under Good Translation Practice (GTP) guidelines aligned with GxP (GMP, GCP, GLP) principles. This includes documented SOPs for translation and review processes, qualification and training records for translators, audit trails, version control, and quality system documentation. Some agencies seek formal validation of their processes for pharmaceutical clients operating under FDA or EMA oversight.
Life sciences translation is among the most expensive professional translation categories. Rates range from $0.22 to $0.50 per source word for major language pairs. A 100-page clinical study report (approximately 30,000 words) might cost $6,600 to $15,000. Full regulatory submission packages (NDA, CTD) with multiple documents across multiple languages represent investments of $50,000 to several hundred thousand dollars.